The "72 vs. 11" Vaccine Claim: A Misleading Comparison — and a Schedule That Then Changed

PolitiFact rated the "72 injections" claim False. HHS appears to have reached 72 by counting every vaccine dose from birth through age 18 as a separate injection — including oral drops and annual flu and COVID-19 shots — while counting Denmark's schedule using combination vaccines to reach the lowest possible total ^[1].

FactCheck.org found the same asymmetry from a different angle: Høeg counted polio, hepatitis B, Hib, and DTaP as separate doses for the U.S., even though most American babies receive them as combination shots, while counting Denmark's and the U.K.'s combination shots as single doses ^[2]. Comparing one country's maximum possible count against another's minimum is not a like-for-like comparison.

Under the 2024 U.S. schedule, PolitiFact found a 2-year-old could be fully vaccinated with as few as 12 injections plus oral drops, and the "72" figure is a count of doses, not injections, over 18 years — with maximum use of combination shots, the real injection total by age 18 could run as low as 19 ^[1].

Fact-checkers agree the clearest comparison is by disease targeted, not doses or injections. As of early 2025, the then-current U.S. schedule targeted 17 diseases, versus a median of 14 among 31 OECD advanced economies ^[2]. A STAT News analysis of 38 national schedules found a similar pattern: an average of 14 diseases recommended for all children, with STAT's 20 closest peer countries averaging 13.6 ^[3]. Before 2026, the U.S. schedule targeted a handful more diseases than many peers — not the vast gap implied by "72 vs. 11."

Denmark, not the U.S., was the real low-end outlier: it recommended only 10 diseases for all children, omitting several the U.S. includes, such as hepatitis B ^[2][3].

The comparison became moot within days. On January 5, 2026, acting CDC Director Jim O'Neill issued a decision memo cutting the number of diseases in the routine childhood schedule from 17 to 11, following a December 5, 2025 presidential memorandum directing HHS to align U.S. recommendations with countries including Denmark, Germany, and Japan ^[4].

RSV was moved to high-risk-only status, and rotavirus, influenza, and hepatitis A shifted from universal recommendation to shared clinical decision-making between parents and providers; measles, polio, and pertussis remain universally recommended for all children ^[4].

STAT's count puts the revised U.S. schedule at 11 diseases — one more than Denmark's 10, and below all but one of its 20 peer countries ^[3]. The "outlier" status the White House graphic complained about no longer exists: the CDC's own policy change has since put the U.S. at the low end of the international range.

The "72 vs. 11" injection comparison that circulated in January 2026 is misleading: it set the U.S. count at its theoretical maximum and Denmark's at its theoretical minimum. A disease-for-disease comparison shows the pre-2026 U.S. schedule was broadly similar to — not dramatically larger than — its developed-country peers, and the CDC's own subsequent policy change has since moved the U.S. to the low end of the international range. Claims that the U.S. vaccine schedule was a dangerous global outlier are not supported by a consistent, like-for-like count.